Chordia Therapeutics


Public lists: Cancer Therapeutics (1137)

Chordia Therapeutics is a biotechnology company spun off from Takeda. Chordia's programs include preclinical CDC-like kinase (CLK) inhibitors with applications in cancer and an adult T cell leukemia lymphoma drug.

Chordia Therapeutics is a biotechnology company spun off from Takeda. Chordia's programs include preclinical CDC-like kinase (CLK) inhibitors with applications in cancer and an adult T cell leukemia lymphoma drug.

Company (Alive / Active)

Phone:

Fax:




Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Chordia Therapeutics $0M Nov 23, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Chordia Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Mitsubishi UFJ CapitalCorporate VentureTokyo, JapanSeries A
Takeda VenturesCorporate VenturePalo Alto, California, United StatesSeries A
SMBC Venture CapitalCorporate VentureTokyo, JapanSeries A
Kyoto University Innovation CapitalVenture CapitalKyoto, JapanSeries A
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)